Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination

Recruiting now · Early Phase 1 · Has a placebo group

Conditions studied: Pain

In brief

Some research suggests that administration of oxytocin with oxycodone may reduce its abuse liability and improve its ability to reduce pain. In a 6-session laboratory study, the investigators will be evaluating the effects of oxycodone and oxytocin (combined and separately, across sessions) on experimentally-induced pain, subjective effects, decision-making, and activation of different neural substrates.

Key facts

Study ID
NCT04218409
Run by
University of Florida
People needed
45
Starts
2021-09-02
Expected to finish
2026-12-31
Last updated by the study team
2026-01-14

Who can join

Age: 21 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.